2025-02-21 |
2025-02-18 |
V
Vente
|
York Charles N II
COO, CFO AND SECRETARY
Dirigeant
|
4 370
-1.7%
11,96
52 278 USD
|
4 370
-1.7%
|
11,96
|
52 278 USD
|
|
2025-02-21 |
2025-02-18 |
V
Vente
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
12 048
-8.6%
11,96
144 130 USD
|
12 048
-8.6%
|
11,96
|
144 130 USD
|
|
2025-02-21 |
2025-02-18 |
V
Vente
|
Dubow Adam
GENERAL COUNSEL
Dirigeant
|
4 646
-10.5%
11,96
55 580 USD
|
4 646
-10.5%
|
11,96
|
55 580 USD
|
|
2024-12-12 |
2024-12-10 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
30 000
-2.8%
13,31
399 339 USD
|
30 000
-2.8%
|
13,31
|
399 339 USD
|
|
2024-11-19 |
2024-11-18 |
V
Vente
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
10 554
-8.9%
13,21
139 420 USD
|
10 554
-8.9%
|
13,21
|
139 420 USD
|
|
2024-11-19 |
2024-11-18 |
V
Vente
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
2 206
-0.2%
13,21
29 142 USD
|
2 206
-0.2%
|
13,21
|
29 142 USD
|
|
2024-11-19 |
2024-11-18 |
V
Vente
|
York Charles N II
COO, CFO AND SECRETARY
Dirigeant
|
2 602
-1.1%
13,21
34 373 USD
|
2 602
-1.1%
|
13,21
|
34 373 USD
|
|
2024-11-19 |
2024-11-18 |
V
Vente
|
Dubow Adam
GENERAL COUNSEL
Dirigeant
|
3 165
-9.0%
13,21
41 810 USD
|
3 165
-9.0%
|
13,21
|
41 810 USD
|
|
2024-11-12 |
2024-11-11 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
10 000
-0.9%
16,10
160 994 USD
|
10 000
-0.9%
|
16,10
|
160 994 USD
|
|
2024-11-12 |
2024-11-08 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
18 255
-1.7%
16,17
295 229 USD
|
18 255
-1.7%
|
16,17
|
295 229 USD
|
|
2024-11-08 |
2024-11-07 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
11 245
-1.0%
16,03
180 287 USD
|
11 245
-1.0%
|
16,03
|
180 287 USD
|
|
2024-11-04 |
2024-10-31 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
500
-0.0%
16,02
8 010 USD
|
500
-0.0%
|
16,02
|
8 010 USD
|
|
2024-09-12 |
2024-09-10 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
30 000
-2.7%
14,22
426 675 USD
|
30 000
-2.7%
|
14,22
|
426 675 USD
|
|
2024-08-19 |
2024-08-16 |
V
Vente
|
York Charles N II
COO, CFO AND SECRETARY
Dirigeant
|
2 633
-1.1%
14,00
36 860 USD
|
2 633
-1.1%
|
14,00
|
36 860 USD
|
|
2024-08-19 |
2024-08-16 |
V
Vente
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
2 232
-0.2%
14,00
31 246 USD
|
2 232
-0.2%
|
14,00
|
31 246 USD
|
|
2024-08-19 |
2024-08-16 |
V
Vente
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
10 681
-9.7%
14,00
149 524 USD
|
10 681
-9.7%
|
14,00
|
149 524 USD
|
|
2024-08-19 |
2024-08-16 |
V
Vente
|
Dubow Adam
GENERAL COUNSEL
Dirigeant
|
3 202
-10.6%
14,00
44 825 USD
|
3 202
-10.6%
|
14,00
|
44 825 USD
|
|
2024-07-17 |
2024-07-16 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
20 000
-1.8%
16,01
320 226 USD
|
20 000
-1.8%
|
16,01
|
320 226 USD
|
|
2024-06-21 |
2024-06-21 |
V
Vente
|
Ramasastry Saira
Administrateur non-exécutif
|
10 000
-19.8%
13,19
131 877 USD
|
10 000
-19.8%
|
13,19
|
131 877 USD
|
|
2024-06-12 |
2024-06-10 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
30 000
-2.6%
12,62
378 588 USD
|
30 000
-2.6%
|
12,62
|
378 588 USD
|
|
2024-05-17 |
2024-05-16 |
V
Vente
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
2 267
-0.2%
16,08
36 450 USD
|
2 267
-0.2%
|
16,08
|
36 450 USD
|
|
2024-05-17 |
2024-05-16 |
V
Vente
|
York Charles N II
COO, CFO AND SECRETARY
Dirigeant
|
2 675
-1.2%
16,08
43 011 USD
|
2 675
-1.2%
|
16,08
|
43 011 USD
|
|
2024-05-17 |
2024-05-16 |
V
Vente
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
7 873
-1.2%
16,08
126 588 USD
|
7 873
-1.2%
|
16,08
|
126 588 USD
|
|
2024-05-17 |
2024-05-16 |
V
Vente
|
Dubow Adam
GENERAL COUNSEL
Dirigeant
|
3 253
-13.0%
16,08
52 304 USD
|
3 253
-13.0%
|
16,08
|
52 304 USD
|
|
2024-05-14 |
2024-05-10 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
10 000
-0.9%
16,37
163 743 USD
|
10 000
-0.9%
|
16,37
|
163 743 USD
|
|
2024-05-03 |
2024-05-03 |
VP
Vente planifiée
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
9 154
-1.4%
17,85
163 417 USD
|
9 154
-1.4%
|
17,85
|
163 417 USD
|
|
2024-05-03 |
2024-05-03 |
VP
Vente planifiée
|
York Charles N II
COO, CFO AND SECRETARY
Dirigeant
|
8 078
-3.6%
17,85
144 214 USD
|
8 078
-3.6%
|
17,85
|
144 214 USD
|
|
2024-05-03 |
2024-05-02 |
VP
Vente planifiée
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
6
-0.0%
17,94
108 USD
|
6
-0.0%
|
17,94
|
108 USD
|
|
2024-05-03 |
2024-05-02 |
VP
Vente planifiée
|
York Charles N II
COO, CFO AND SECRETARY
Dirigeant
|
200
-0.1%
17,90
3 579 USD
|
200
-0.1%
|
17,90
|
3 579 USD
|
|
2024-05-03 |
2024-05-01 |
VP
Vente planifiée
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
70 051
-9.7%
17,88
1 252 183 USD
|
70 051
-9.7%
|
17,88
|
1 252 183 USD
|
|
2024-05-03 |
2024-05-01 |
VP
Vente planifiée
|
York Charles N II
COO, CFO AND SECRETARY
Dirigeant
|
52 183
-18.8%
17,89
933 397 USD
|
52 183
-18.8%
|
17,89
|
933 397 USD
|
|
2024-04-22 |
2024-04-18 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
10 000
-0.8%
16,02
160 163 USD
|
10 000
-0.8%
|
16,02
|
160 163 USD
|
|
2024-03-26 |
2024-03-25 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
10 000
-0.8%
16,01
160 055 USD
|
10 000
-0.8%
|
16,01
|
160 055 USD
|
|
2024-03-13 |
2024-03-11 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
30 000
-2.4%
15,24
457 314 USD
|
30 000
-2.4%
|
15,24
|
457 314 USD
|
|
2024-02-28 |
2024-02-27 |
VP
Vente planifiée
|
Blackman Samuel C.
HEAD OF R&D
Dirigeant
|
20 000
-1.6%
16,11
322 166 USD
|
20 000
-1.6%
|
16,11
|
322 166 USD
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
Blackman Samuel C.
HEAD OF RESEARCH AND DEVELOPME
Dirigeant
|
2 258
-0.2%
15,25
34 430 USD
|
2 258
-0.2%
|
15,25
|
34 430 USD
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
Dubow Adam
GENERAL COUNSEL
Dirigeant
|
3 242
-16.4%
15,25
49 434 USD
|
3 242
-16.4%
|
15,25
|
49 434 USD
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
York Charles N II
COO, CFO AND SECRETARY
Dirigeant
|
2 666
-1.0%
15,25
40 651 USD
|
2 666
-1.0%
|
15,25
|
40 651 USD
|
|
2024-02-20 |
2024-02-16 |
V
Vente
|
Bender Jeremy
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
7 615
-1.0%
15,25
116 114 USD
|
7 615
-1.0%
|
15,25
|
116 114 USD
|
|
2023-11-17 |
2023-11-16 |
V
Vente
|
Dubow Adam
General Counsel
Dirigeant
|
5 313
-31.7%
11,69
62 109 USD
|
5 313
-31.7%
|
11,69
|
62 109 USD
|
|
2023-11-17 |
2023-11-16 |
V
Vente
|
Blackman Samuel C.
Head of Research and Developme
Dirigeant
|
709
-0.1%
11,69
8 288 USD
|
709
-0.1%
|
11,69
|
8 288 USD
|
|
2023-11-17 |
2023-11-16 |
V
Vente
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
3 107
-0.4%
11,69
36 321 USD
|
3 107
-0.4%
|
11,69
|
36 321 USD
|
|
2023-11-17 |
2023-11-16 |
V
Vente
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
956
-0.4%
11,69
11 176 USD
|
956
-0.4%
|
11,69
|
11 176 USD
|
|
2023-10-20 |
2023-10-20 |
A
Achat
|
AI Day1 LLC
Affiliate of 10% Owner
Actionnaire important
|
111 387
+0.9%
9,97
1 110 907 USD
|
111 387
+0.9%
|
9,97
|
1 110 907 USD
|
|
2023-10-20 |
2023-10-19 |
A
Achat
|
AI Day1 LLC
Affiliate of 10% Owner
Actionnaire important
|
384 400
+3.1%
10,06
3 867 372 USD
|
384 400
+3.1%
|
10,06
|
3 867 372 USD
|
|
2023-10-20 |
2023-10-18 |
A
Achat
|
AI Day1 LLC
Affiliate of 10% Owner
Actionnaire important
|
979 667
+8.6%
10,21
10 000 049 USD
|
979 667
+8.6%
|
10,21
|
10 000 049 USD
|
|
2023-08-17 |
2023-08-17 |
V
Vente
|
Blackman Samuel C.
Head of Research and Developme
Dirigeant
|
668
-0.1%
13,86
9 258 USD
|
668
-0.1%
|
13,86
|
9 258 USD
|
|
2023-08-17 |
2023-08-17 |
V
Vente
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
2 996
-0.4%
13,86
41 525 USD
|
2 996
-0.4%
|
13,86
|
41 525 USD
|
|
2023-08-17 |
2023-08-17 |
V
Vente
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
922
-0.3%
13,86
12 779 USD
|
922
-0.3%
|
13,86
|
12 779 USD
|
|
2023-06-12 |
2023-06-09 |
A
Achat
|
AI Day1 LLC
Affiliate of 10% Owner
Actionnaire important
|
769 230
+7.2%
13,00
9 999 990 USD
|
769 230
+7.2%
|
13,00
|
9 999 990 USD
|
|
2023-06-07 |
2023-06-05 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
1 229
-0.1%
16,00
19 664 USD
|
1 229
-0.1%
|
16,00
|
19 664 USD
|
|
2023-05-17 |
2023-05-16 |
V
Vente
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
3 104
-0.3%
13,12
40 732 USD
|
3 104
-0.3%
|
13,12
|
40 732 USD
|
|
2023-05-17 |
2023-05-16 |
V
Vente
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
692
-0.1%
13,12
9 081 USD
|
692
-0.1%
|
13,12
|
9 081 USD
|
|
2023-05-17 |
2023-05-16 |
V
Vente
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
955
-0.4%
13,12
12 532 USD
|
955
-0.4%
|
13,12
|
12 532 USD
|
|
2023-03-14 |
2023-03-10 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
10 000
-0.8%
18,05
180 484 USD
|
10 000
-0.8%
|
18,05
|
180 484 USD
|
|
2023-03-08 |
2023-03-07 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
12 500
-1.1%
20,01
250 114 USD
|
12 500
-1.1%
|
20,01
|
250 114 USD
|
|
2023-03-03 |
2023-03-01 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
25 000
-7.0%
18,61
465 303 USD
|
25 000
-7.0%
|
18,61
|
465 303 USD
|
|
2023-02-21 |
2023-02-17 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
9 377
-3.5%
20,03
187 790 USD
|
9 377
-3.5%
|
20,03
|
187 790 USD
|
|
2023-02-17 |
2023-02-16 |
V
Vente
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
3 022
-0.3%
19,57
59 150 USD
|
3 022
-0.3%
|
19,57
|
59 150 USD
|
|
2023-02-17 |
2023-02-16 |
V
Vente
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
930
-0.3%
19,57
18 203 USD
|
930
-0.3%
|
19,57
|
18 203 USD
|
|
2023-02-17 |
2023-02-16 |
V
Vente
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
674
-0.1%
19,57
13 192 USD
|
674
-0.1%
|
19,57
|
13 192 USD
|
|
2023-02-13 |
2023-02-10 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
10 000
-0.8%
20,07
200 659 USD
|
10 000
-0.8%
|
20,07
|
200 659 USD
|
|
2023-02-03 |
2023-02-01 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
1 106
-0.3%
21,69
23 988 USD
|
1 106
-0.3%
|
21,69
|
23 988 USD
|
|
2023-02-03 |
2023-02-01 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
23 894
-6.3%
21,21
506 806 USD
|
23 894
-6.3%
|
21,21
|
506 806 USD
|
|
2023-01-24 |
2023-01-23 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
12 500
-1.0%
22,00
274 988 USD
|
12 500
-1.0%
|
22,00
|
274 988 USD
|
|
2023-01-23 |
2023-01-20 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
10 000
-3.6%
22,75
227 523 USD
|
10 000
-3.6%
|
22,75
|
227 523 USD
|
|
2023-01-11 |
2023-01-10 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
2 500
-0.2%
23,20
58 011 USD
|
2 500
-0.2%
|
23,20
|
58 011 USD
|
|
2023-01-11 |
2023-01-10 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
7 500
-0.6%
22,75
170 633 USD
|
7 500
-0.6%
|
22,75
|
170 633 USD
|
|
2023-01-04 |
2023-01-03 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
7 610
-2.0%
21,31
162 174 USD
|
7 610
-2.0%
|
21,31
|
162 174 USD
|
|
2023-01-04 |
2023-01-03 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
17 390
-4.3%
20,36
353 973 USD
|
17 390
-4.3%
|
20,36
|
353 973 USD
|
|
2022-12-22 |
2022-12-21 |
VP
Vente planifiée
|
Bender Jeremy
Chief Executive Officer
Administrateur exécutif
|
12 500
-1.0%
20,32
253 969 USD
|
12 500
-1.0%
|
20,32
|
253 969 USD
|
|
2022-12-22 |
2022-12-20 |
VP
Vente planifiée
|
York Charles N II
COO, CFO and Secretary
Dirigeant
|
10 000
-3.5%
20,07
200 650 USD
|
10 000
-3.5%
|
20,07
|
200 650 USD
|
|
2022-12-12 |
2022-12-08 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
4 358
-1.1%
22,08
96 210 USD
|
4 358
-1.1%
|
22,08
|
96 210 USD
|
|
2022-12-05 |
2022-12-02 |
VP
Vente planifiée
|
Grant Julie Papanek
Administrateur non-exécutif
|
5 000
-1.2%
21,55
107 726 USD
|
5 000
-1.2%
|
21,55
|
107 726 USD
|
|
2022-12-05 |
2022-12-01 |
VP
Vente planifiée
|
Blackman Samuel C.
Chief Medical Officer
Dirigeant
|
900
-0.1%
22,16
19 940 USD
|
900
-0.1%
|
22,16
|
19 940 USD
|
|